Clearside Biomedical Inc (CLSD)
1.34
+0.08
(+6.35%)
USD |
NASDAQ |
Apr 26, 16:00
1.30
-0.04
(-2.99%)
Pre-Market: 20:00
Clearside Biomedical Market Cap: 100.13M for April 26, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| April 26, 2024 | 100.13M |
| April 25, 2024 | 94.15M |
| April 24, 2024 | 100.13M |
| April 23, 2024 | 102.37M |
| April 22, 2024 | 105.36M |
| April 19, 2024 | 97.88M |
| April 18, 2024 | 98.63M |
| April 17, 2024 | 94.15M |
| April 16, 2024 | 85.93M |
| April 15, 2024 | 96.39M |
| April 12, 2024 | 93.40M |
| April 11, 2024 | 97.14M |
| April 10, 2024 | 92.65M |
| April 09, 2024 | 96.39M |
| April 08, 2024 | 96.39M |
| April 05, 2024 | 97.14M |
| April 04, 2024 | 99.38M |
| April 03, 2024 | 106.85M |
| April 02, 2024 | 104.61M |
| April 01, 2024 | 118.06M |
| March 28, 2024 | 114.32M |
| March 27, 2024 | 124.78M |
| March 26, 2024 | 126.28M |
| March 25, 2024 | 129.27M |
| March 22, 2024 | 127.77M |
| Date | Value |
|---|---|
| March 21, 2024 | 134.50M |
| March 20, 2024 | 121.80M |
| March 19, 2024 | 121.80M |
| March 18, 2024 | 116.56M |
| March 15, 2024 | 127.77M |
| March 14, 2024 | 129.27M |
| March 13, 2024 | 121.80M |
| March 12, 2024 | 122.54M |
| March 11, 2024 | 150.94M |
| March 08, 2024 | 124.78M |
| March 07, 2024 | 124.78M |
| March 06, 2024 | 112.83M |
| March 05, 2024 | 103.86M |
| March 04, 2024 | 103.86M |
| March 01, 2024 | 103.86M |
| February 29, 2024 | 104.61M |
| February 28, 2024 | 105.36M |
| February 27, 2024 | 104.24M |
| February 26, 2024 | 100.13M |
| February 23, 2024 | 101.62M |
| February 22, 2024 | 99.38M |
| February 21, 2024 | 97.14M |
| February 20, 2024 | 96.39M |
| February 16, 2024 | 93.40M |
| February 15, 2024 | 91.16M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
22.12M
Minimum
Sep 03 2019
428.25M
Maximum
Aug 27 2021
112.14M
Average
84.87M
Median
Nov 15 2022
Market Cap Benchmarks
| Cassava Sciences Inc | 965.65M |
| Heron Therapeutics Inc | 368.31M |
| Actinium Pharmaceuticals Inc | 201.95M |
| Karyopharm Therapeutics Inc | 121.97M |
| Ocular Therapeutix Inc | 705.24M |
Market Cap Related Metrics
| PS Ratio | 10.07 |
| Price | 1.34 |
| Earnings Yield | -39.55% |